scholarly journals Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load

2006 ◽  
Vol 43 (Supplement 1) ◽  
pp. S23-S35 ◽  
Author(s):  
Jane M Simoni ◽  
Cynthia R Pearson ◽  
David W Pantalone ◽  
Gary Marks ◽  
Nicole Crepaz
Keyword(s):  
Viral Load ◽  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Therapy Adherence ◽  
Highly Active ◽  
Antiretroviral Therapy Adherence ◽  
Hiv 1

Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

AIDS ◽  
2001 ◽  
Vol 15 (6) ◽  
pp. 665-673 ◽  
Author(s):  
Nicole Ngo-Giang-Huong ◽  
Christiane Deveau ◽  
Isabelle Da Silva ◽  
Isabelle Pellegrin ◽  
Alain Venet ◽  
...  
Keyword(s):  
Viral Load ◽  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Plasma Viral Load ◽  
Highly Active ◽  
One Year ◽  
Hiv 1

Changes in HIV‐1 viral load trends with highly active antiretroviral therapy

2001 ◽  
Vol 174 (4) ◽  
pp. 199-200 ◽  
Author(s):  
Choo B Chew ◽  
Marcel J Lerol ◽  
Cassy Workman ◽  
Dominic E Dwyer
Keyword(s):  
Viral Load ◽  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Highly Active ◽  
Hiv 1

scholarly journals Highly active antiretroviral therapy adherence and its determinants in selected regions in Indonesia

2011 ◽  
pp. 50
Author(s):  
Felix F. Widjaja ◽  
Caroline G. Puspita ◽  
Ferdi Daud ◽  
Ienag Yudhistrie ◽  
Marita R. Tiara ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Therapy Adherence ◽  
Highly Active ◽  
Antiretroviral Therapy Adherence

scholarly journals In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months

2003 ◽  
Vol 77 (3) ◽  
pp. 2271-2275 ◽  
Author(s):  
Michele Di Mascio ◽  
Geethanjali Dornadula ◽  
Hui Zhang ◽  
Julie Sullivan ◽  
Yan Xu ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Viral Load ◽  
Antiretroviral Therapy ◽  
Human Immunodeficiency Virus Type ◽  
Virus Type ◽  
Highly Active Antiretroviral Therapy ◽  
Half Life ◽  
Highly Active ◽  
Immunodeficiency Virus ◽  
Hiv 1

ABSTRACT Three of five virally suppressed human immunodeficiency virus type I (HIV-1)-infected patients treated with highly active antiretroviral therapy and followed intensively with a supersensitive reverse transcriptase PCR assay with a lower limit of quantitation of 5 copies/ml showed statistically significant viral load decays below 50 copies/ml, with half-lives of 5 to 8 months and a mean of 6 months. This range of half-lives is consistent with the estimated half-life of the latent HIV-1 reservoir in the peripheral blood. Those patients without decay of viral load in plasma may have significant cryptic HIV-1 residual replication.

Sign in / Sign up

Export Citation Format

Share Document